Not applicableStudy completedNCT05192863What this trial is testingVedolizumab in Adults With Crohn's Disease (CD)Who this might be right forCrohn's Disease Takeda 72
Large-scale testing (Phase 3)Looking for participantsNCT07499232What this trial is testingGuselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Janssen Research & Development, LLC 530
Testing effectiveness (Phase 2)Ended earlyNCT04277546What this trial is testingOpen-label Extension Study of Brazikumab in Ulcerative ColitisWho this might be right forUlcerative Colitis AstraZeneca 57
Large-scale testing (Phase 3)Study completedNCT03283085What this trial is testingA Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)Who this might be right forCrohn's DiseaseUlcerative Colitis Shire 557
Large-scale testing (Phase 3)Study completedNCT02531126What this trial is testingAn Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis Celgene 877
Testing effectiveness (Phase 2)Study completedNCT00306215What this trial is testingEvaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Amgen 436
Large-scale testing (Phase 3)Ended earlyNCT03758443What this trial is testingEfficacy & Safety of TD-1473 in Ulcerative ColitisWho this might be right forUlcerative Colitis (UC) Theravance Biopharma 239
Testing effectiveness (Phase 2)Study completedNCT02031276What this trial is testingEfficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.Who this might be right forCrohn Disease AbbVie 121
Large-scale testing (Phase 3)Active Not RecruitingNCT05197049What this trial is testingGuselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Janssen Research & Development, LLC 350
Testing effectiveness (Phase 2)WithdrawnNCT01635621What this trial is testingA Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's DiseaseWho this might be right forCrohn's Disease UCB BIOSCIENCES GmbH
Testing effectiveness (Phase 2)Study completedNCT00615199What this trial is testingInvestigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Pfizer 139
Large-scale testing (Phase 3)Active Not RecruitingNCT04524611What this trial is testingStudy Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)Who this might be right forCrohn's Disease (CD) AbbVie 527
Large-scale testing (Phase 3)Active Not RecruitingNCT06880744What this trial is testingAssess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to VedolizumabWho this might be right forUlcerative Colitis AbbVie 573
Large-scale testing (Phase 3)Active Not RecruitingNCT04738942What this trial is testingIntravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseWho this might be right forUlcerative ColitisCrohn's Disease Takeda 56
Large-scale testing (Phase 3)Study completedNCT01458951What this trial is testingEvaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Pfizer 547
Testing effectiveness (Phase 2)WithdrawnNCT05121402What this trial is testingSafety and Efficacy Study of TLL018 in the Treatment of Ulcerative ColitisWho this might be right forUlcerative Colitis TLL Pharmaceutical, LLC
Large-scale testing (Phase 3)Ended earlyNCT03440372What this trial is testingInduction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Celgene 625
Early research (Phase 1)Not Yet RecruitingNCT07744646What this trial is testingAlpha-0261 Tablets for Moderate-to-Severe Ulcerative ColitisWho this might be right forUlcerative Colitis (UC) The First Affiliated Hospital of Anhui Medical University 10
Testing effectiveness (Phase 2)Looking for participantsNCT06548542What this trial is testingStudy of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease AbbVie 590
Testing effectiveness (Phase 2)Ended earlyNCT03329885What this trial is testingExperimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious PsoriasisWho this might be right forRheumatoid ArthritisPsoriasisAnkylosing Spondylitis+2 more Bristol-Myers Squibb 38